BBGBloomberg·2hBusiness
score+0.70
Shionogi-Backed Biotech Apnimed Raises $192 Million in US IPO
Original
Shionogi-Backed Biotech Apnimed Raises $192 Million in US IPO
“Highlights successful capital raise and pricing at the top of the range, indicating strong market confidence.”